Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). [electronic resource] by
- Condorelli, R
- Mosele, F
- Verret, B
- Bachelot, T
- Bedard, P L
- Cortes, J
- Hyman, D M
- Juric, D
- Krop, I
- Bieche, I
- Saura, C
- Sotiriou, C
- Cardoso, F
- Loibl, S
- Andre, F
- Turner, N C
Producer: 20200324
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|